Texas Permanent School Fund Biogen Inc. Transaction History

Texas Permanent School Fund

$11 Billion
Q2 2024

A detailed history of Texas Permanent School Fund transactions in Biogen Inc. stock. As of the latest transaction made, Texas Permanent School Fund holds 23,960 shares of BIIB stock, worth $4.16 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

23,960

Previous 29,963 20.03%

Holding current value

$4.16 Million

Previous $6.46 Million 14.02%

% of portfolio

0.05%

Previous 0.05%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$190.52 - $236.72 $1.14 Million - $1.42 Million	-6,003 Reduced 20.03%	23,960 $5.55 Million
Q1 2024 May 03, 2024	BUY	$212.02 - $267.71 $7,420 - $9,369	35 Added 0.12%	29,963 $6.46 Million
Q4 2023 Feb 08, 2024	SELL	$222.59 - $267.94 $1,558 - $1,875	-7 Reduced 0.02%	29,928 $7.74 Million
Q3 2023 Nov 09, 2023	SELL	$253.3 - $285.89 $35,715 - $40,310	-141 Reduced 0.47%	29,935 $7.69 Million
Q2 2023 Aug 07, 2023	BUY	$275.25 - $318.06 $14,863 - $17,175	54 Added 0.18%	30,076 $8.57 Million
Q1 2023 May 01, 2023	BUY	$256.56 - $292.34 $2.41 Million - $2.74 Million	9,387 Added 45.49%	30,022 $8.35 Million
Q4 2022 Feb 07, 2023	BUY	$252.44 - $306.72 $25,748 - $31,285	102 Added 0.5%	20,635 $5.71 Million
Q3 2022 Oct 25, 2022	BUY	$194.69 - $268.46 $231,681 - $319,467	1,190 Added 6.15%	20,533 $5.48 Million
Q2 2022 Aug 08, 2022	BUY	$187.54 - $223.02 $54,386 - $64,675	290 Added 1.52%	19,343 $3.95 Million
Q1 2022 May 06, 2022	SELL	$193.77 - $244.14 $228,261 - $287,596	-1,178 Reduced 5.82%	19,053 $4.01 Million
Q4 2021 Feb 08, 2022	SELL	$223.92 - $287.77 $625,408 - $803,741	-2,793 Reduced 12.13%	20,231 $4.85 Million
Q3 2021 Oct 28, 2021	SELL	$282.99 - $369.05 $562,584 - $733,671	-1,988 Reduced 7.95%	23,024 $6.52 Million
Q2 2021 Jul 27, 2021	SELL	$259.0 - $414.71 $110,334 - $176,666	-426 Reduced 1.67%	25,012 $8.66 Million
Q1 2021 May 03, 2021	SELL	$242.95 - $284.63 $411,314 - $481,878	-1,693 Reduced 6.24%	25,438 $7.12 Million
Q4 2020 Feb 04, 2021	SELL	$236.26 - $355.63 $458,344 - $689,922	-1,940 Reduced 6.67%	27,131 $6.64 Million
Q3 2020 Nov 06, 2020	BUY	$264.77 - $305.71 $83,402 - $96,298	315 Added 1.1%	29,071 $8.25 Million
Q2 2020 Aug 04, 2020	SELL	$258.66 - $342.55 $1.03 Million - $1.37 Million	-4,000 Reduced 12.21%	28,756 $7.69 Million
Q1 2020 Apr 27, 2020	BUY	$268.85 - $341.04 $222,338 - $282,040	827 Added 2.59%	32,756 $10.4 Million
Q4 2019 Feb 03, 2020	SELL	$220.06 - $304.07 $534,525 - $738,586	-2,429 Reduced 7.07%	31,929 $9.47 Million
Q3 2019 Oct 31, 2019	SELL	$217.44 - $243.88 $659,712 - $739,931	-3,034 Reduced 8.11%	34,358 $8 Million
Q2 2019 Aug 09, 2019	SELL	$219.29 - $241.72 $192,317 - $211,988	-877 Reduced 2.29%	37,392 $8.75 Million
Q1 2019 May 02, 2019	SELL	$216.71 - $338.96 $488,897 - $764,693	-2,256 Reduced 5.57%	38,269 $9.05 Million
Q4 2018 Feb 11, 2019	SELL	$278.5 - $352.75 $1.31 Million - $1.66 Million	-4,696 Reduced 10.38%	40,525 $12.2 Million
Q3 2018 Oct 22, 2018	SELL	$293.51 - $383.83 $1.84 Million - $2.41 Million	-6,270 Reduced 12.18%	45,221 $16 Million
Q2 2018 Jul 23, 2018	SELL	$257.52 - $306.91 $816,853 - $973,518	-3,172 Reduced 5.8%	51,491 $14.9 Million
Q1 2018 Apr 20, 2018	SELL	$260.13 - $367.91 $795,477 - $1.13 Million	-3,058 Reduced 5.3%	54,663 $15 Million
Q4 2017 Jan 23, 2018	SELL	$307.64 - $344.58 $268,569 - $300,818	-873 Reduced 1.49%	57,721 $18.4 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $16.5 Million - $19.3 Million	58,594	58,594 $18.3 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.

Account

Texas Permanent School Fund Biogen Inc. Transaction History